Due to staff annual leave, please expect a delay in response time to your helpdesk queries. We will answer as soon as we can, but in the interim we kindly ask you to refrain from creating duplicate tickets for the same issue. - Thanks EGA team

The European Genome-phenome Archive (EGA) is a service for permanent archiving and sharing of personally identifiable genetic, phenotypic, and clinical data generated for the purposes of biomedical research projects or in the context of research-focused healthcare systems.
  • Latest studies

    Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy. – 2021-10-05

    We derived PDAC organoids from primary tumors of 18 patients, together with two matched samples from liver metastases. By single-cell RNA sequencing, we show that PDAC organoids consist o Read more

     Study 1 / 5

    Published in:
  • Latest studies

    Determinants of renal cell carcinoma invasion and metastatic competence. – 2021-10-04

    We prospectively enrolled 83 patients with a renal mass and TT scheduled to undergo surgical resection. To accurately integrate genomic and transcriptomic findings and enable histological Read more

     Study 2 / 5

    Published in:
  • Latest studies

    Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. – 2021-09-30

    Bottleneck Sequencing Of Human Tissue Wgs Read more

     Study 3 / 5

    Published in:
  • Latest studies

    Mapping the human genetic architecture of COVID-19 – 2021-08-21

    The COVID-19 host genetics initiative is a bottom-up collaborative effort that has three main goals: 1. Provide an environment to foster the sharing of resources to facilitate COVID-19 ho Read more

     Study 4 / 5

    Published in:
  • Latest studies

    The growing need for controlled data access models in clinical proteomics and metabolomics. – 2021-10-01

    Telomere maintenance by telomerase activation or alternative lengthening of telomeres (ALT) is a major determinant of poor outcome in neuroblastoma. Here, we screen for ALT in primary and Read more

     Study 5 / 5

    Published in:
  • What is in the EGA?